Skip to Content
Upcoming Webinar

Evolving Needs and a Treatment Option for R/R Multiple Myeloma

Date: November 18, 2026 | 2:00 PM

 

 

 

How does ZENBEXUS compare with historical immunomodulatory drugs, and what do the efficacy and safety data show?

Tony Wang, PharmD, JD, walks through its mechanism of action, results for ZENBEXUS with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), and safety findings from EXCALIBER-RRMM and the ZENBEXUS label.

What we’ll cover:

  • How ZENBEXUS works compared with historical immunomodulatory drugs
  • Efficacy data for the ZDd regimen
  • Safety findings from EXCALIBER-RRMM and the ZENBEXUS label

Reach out to Johnny Rivera at [email protected] with any questions or login assistance.